Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If the 148 has expired

Why does Patriot still show it as one of three patents elemental to every microprocessor. Notice the expiration date of 2015 below. If it did expire last year, shouldn't Patriot have corrected the information on its website and wouldn't this have been a material event that Patriot should have stated in their quarterly reports. Does anyone remember seeing anything in the SEC filings about this patent expiring? What about the other patents - is anything expiring before 2015?

Licensing

Patriot Scientific (OTC Bulletin Board: PTSC) and The TPL Group have unified their interests in a portfolio of fundamental microprocessor patents that are at the heart of a global microprocessor end-use market. The unification was achieved through a joint venture established via agreements entered into between Patriot Scientific and TPL in June 2005. Patriot and TPL each own 50% of the joint venture and share in the proceeds of licensing activities as distributed by the joint venture pursuant to the agreements. Alliacense, a TPL Group entity, is responsible for the commercialization and licensing of this patent portfolio.

<!-- <p>Founded in 1988, Silicon Valley-based TPL has a solid track record in delivering a complete suite of intellectual property management services. In addition to optimizing IP portfolio value and protecting assets from infringement, the company is also well versed in converting portfolio value into a maximum cash return for its owner(s). Through Alliacense, the TPL Group manages IP-licensing programs across a broad array of industries.</p> <p>Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP-licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL's intellectual property portfolios.</p> -->

The patent portfolio, marketed as the Moore Microprocessor Patent (MMP) Portfolio, contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses several U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors, and system-on-chip (SoC) implementations. Patriot Scientific and TPL believe at least three of the patents are elemental to virtually every microprocessor design. The three most significant of these patents are as follows:

  • U.S. 5,809,336: Clocking CPU and I/O Separately
  • U.S. 6,598,148: Use of Multiple Cores and Embedded Memory
  • U.S. 5,784,584: Multiple Instruction Fetch

Both Patriot Scientific and The TPL Group assert that these patents, which were granted in 1998 and which are valid through 2015, have long been essential to the design of modern high-speed microprocessors.

Share
New Message
Please login to post a reply